← All organizations
First clinical trial
Apr 1, 2007Last known activity
Dec 1, 2011
Acquired by CTI BioPharma → Swedish Orphan Biovitrum → Advent International on May 1, 2012
Timeline
2000s
- Jun 1, 2000
S*BIO— Founded
2010s
- May 1, 2012
CTI BioPharma— Acquired By
2020s
- Sep 8, 2021
Advent International— Now
Drugs by trial phase (4 distinct, 8 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Hodgkin Disease
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Mantle-Cell
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasms
- Polycythemia
- Polycythemia Vera
- Preleukemia
- Primary Myelofibrosis
- Thrombocythemia, Essential
- Thrombocytosis
Recent trials (8)
- NCT01436084CollaboratorPhase 2Dec 1, 2011
- NCT01263899Lead sponsorPhase 2Dec 1, 2010
- NCT01200498CollaboratorPhase 2Nov 1, 2010
- NCT01235871Lead sponsorPhase 1Aug 1, 2010
- NCT00745550Lead sponsorPhase 1/Phase 2Aug 1, 2008
- NCT00719836Lead sponsorPhase 1/Phase 2Aug 1, 2008
- NCT00741871Lead sponsorPhase 1Jul 1, 2008
- NCT00741234Lead sponsorPhase 1Apr 1, 2007
Details
- Founded
- Singapore, SG Jun 1, 2000
- Last known activity
- Dec 1, 2011